EGFR and non-small cell lung carcinoma: Our analysis also showed that Beclin 1, EGFR and ALK are independently associated with PFS and are significant predictors for PFS in the patient with non-squamous NSCLC with AUCs above 0.70, suggesting that they may be used as standing alone biomarkers or in combination with other diagnostic tools to precisely predict the outcome of therapeutic plan.